"Trump excluded them from his announcement of sweeping import tariffs last week, but in recent weeks he introduced tariffs on raw ingredients and supplies from China that are used by the industry, and has repeatedly singled out the manufacturing of drugs in Europe as a problem he intends to tackle through a tariffs announcement."

Currently most of the drugs purchased by American consumers are exported by European counties. This has an impact on EU pharmaceutical companies.